Bellevue Group Ag Essa Pharma Inc. Transaction History
Bellevue Group Ag
- $5.98 Billion
- Q2 2024
A detailed history of Bellevue Group Ag transactions in Essa Pharma Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 7,889,583 shares of EPIX stock, worth $45.8 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
7,889,583
Previous 7,889,583
-0.0%
Holding current value
$45.8 Million
Previous $67 Million
38.04%
% of portfolio
0.69%
Previous 1.05%
Shares
7 transactions
Others Institutions Holding EPIX
# of Institutions
34Shares Held
35.2MCall Options Held
37.7KPut Options Held
3.8K-
Bvf Inc San Francisco, CA8.75MShares$50.8 Million1.41% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.21MShares$24.5 Million2.24% of portfolio
-
Morgan Stanley New York, NY4.18MShares$24.3 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.97MShares$17.2 Million0.8% of portfolio
-
Rtw Investments, LP New York, NY2.3MShares$13.4 Million0.2% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $256M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...